|
Efgartigimod PH20 SC Clinical Trials
1 actively recruiting trial across 1 location
Charlotte, North Carolina1 trial
A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis
Carolinas HealthCare System Neurosciences Institute - Neurology
Phase 2/3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.